Health Sector – UHC, National Health Policy, Family Planning, Health Insurance, etc.

India short of 6 lakh doctors, 2 million nurses: U.S. study


From UPSC perspective, the following things are important :

Prelims level : Not Much

Mains level : Healthcare lacunae in India

  • India has a shortage of an estimated 600,000 doctors and 2 million nurses, say a US study.

Out-of-pocket costs of health

  • In India, 65% of health expenditure is out-of-pocket, and such expenditures push some 57 million people into poverty each year.
  • Even when antibiotics are available, patients are often unable to afford them.
  • High out-of-pocket medical costs to the patient are compounded by limited government spending for health services.
  • The study found that lack of staff that are properly trained in administering antibiotics is preventing patients from accessing live-saving drugs.

Mortality burden

  • Researchers at CDDEP in the U.S. conducted stakeholder interviews in Uganda, India, and Germany, and literature reviews to identify key access barriers to antibiotics in low-, middle-, and high-income countries.
  • The majority of the world’s annual 5.7 million antibiotic-treatable deaths occur in low- and middle-income countries.
  • Here, the mortality burden from treatable bacterial infections far exceeds the estimated annual 700,000 deaths from antibiotic-resistant infections.
  • Health facilities in many of these countries are substandard.

Issues with India

  • In India, there is one government doctor for every 10,189 people (the WHO recommends a ratio of 1:1,000), or there is a deficit of 600,000 doctors.
  • The nurse: patient ratio is 1:483, implying a shortage of two million nurses.
  • Lack of access to antibiotics kills more people currently than does antibiotic resistance, but we have not had a good handle on why these barriers are created.
  • The findings of the report show that even after the discovery of new antibiotic, regulatory hurdles and substandard health facilities delay or altogether prevent widespread market entry and drug availability.
Notify of
Inline Feedbacks
View all comments